Should Match Stock’s New High Stop You From Buying?
For questions about this article or underlying research, email help@trefis.com.
Every investor knows the rule to buy low and never at the top, and it is hard to forget with Match Group (MTCH) stock sitting at a 52-week high. The shares closed at that peak on October 20, 2026, making it the wrong time to buy according to the rule. A more useful question is what happened to the investors who bought Match at its earlier highs. Does that rule hold for Match?
Why Match Stock Is At A High
Match stock is up 40.4% over the past year before dividends, and higher earnings account for most of that gain. Net income rose 31.6% over the twelve months ending in June 2026, compared with the prior twelve-month period. The price-to-earnings multiple, which measures what investors pay for each dollar of profit, moved only from 14.2 to 15.2.
Match generated higher profit without selling much more, as revenue grew 1.7% over the same twelve months. Cost of revenue fell 16% in the second quarter of 2026, a decline management attributed mainly to alternative payment savings.
The growth inside Match comes from Hinge, where direct revenue rose 22% in that quarter while direct revenue at Tinder slipped 1%.
Highs like this test every retirement plan. If your advisor recently retired, it is a good moment for a free second opinion from our partner firm.
What Happened After Match Stock’s Earlier Highs?
Take a guess first: after how many of its earlier 52-week highs was Match stock higher a year later? The answer is six of nine, counting the highs since November 2016 with a full year of trading after them, capped at one every 126 trading sessions. Each of the nine highs is listed below alongside the stock’s performance over the following year.
| 52-week high | Stock a year later | S&P 500, same year | Lowest point in that year |
|---|---|---|---|
| May 2017 | +102.7% | +13.9% | -14.9% |
| Nov 2017 | +47.6% | +8.2% | -4.6% |
| Aug 2018 | +67.7% | +1.0% | -26.4% |
| Apr 2019 | +23.8% | -4.2% | -21.3% |
| Jan 2020 | +116.2% | +13.6% | -48.8% |
| Aug 2020 | +43.5% | +34.3% | -7.6% |
| Feb 2021 | -27.4% | +15.8% | -33.4% |
| Oct 2021 | -75.5% | -17.5% | -76.4% |
| Aug 2025 | -2.0% | +20.4% | -25.4% |
A 52-week high is a close above every close of the 252 trading sessions before it, counted no more than once every 126 trading sessions. A year later is the close 252 trading sessions after the high. Changes are measured from the close on the day of the high; 0.0% in the last column means the stock did not close below it. Split-adjusted closing prices, dividends excluded.
The middle result was a gain of 43.5% a year later. A buyer at a high has therefore come out ahead more often than not.
Is A High A Worse Time To Buy?
That has not been true for Match so far. A purchase made on any trading day from November 2016 to October 2025 yielded a middle result of a 10.0% gain a year later, falling well short of the result after a high. In Match’s own history, buying at a high has usually worked out, and the middle result has beaten purchases made on an ordinary day.
What Should A Buyer At A High Expect?
The traditional rule is not foolish, and the October 2021 high demonstrates why: a year later, in October 2022, Match stock was 75.5% lower. That marked the worst of the nine highs rather than the usual outcome.
Most buyers at a high did face a deep dip along the way. Six of the nine highs were followed by a close 20% or more below the buying price within the year. After its earlier highs, Match stock typically sat 25.4% below the buying price at its lowest close within the year, which is the dip a buyer at a high should be ready for.
Your Advisor Retired? Get A Second Opinion Before You Settle
A new high makes Match holders wonder whether they are late. When the advisor who built your plan moves on, it is a natural moment to ask whether the plan still fits the life you have now. Our partner advisory firm offers a free review of your holdings, fees and income plan.
Spot an error or want more like this? Tell us in 10 seconds.